The INTENT Study
The Infancy to Toddlerhood: Early Nutrition and Tolerance (INTENT) study is a direct-to-participant digital health clinical trial evaluating SpoonfulONE as a complementary feeding strategy for early food allergen introduction in infants and toddlers.
The INTENT virtual study is randomized, controlled, and open-label. We enrolled infants between the ages of 4-6 months, including infants with eczema.
Participants are randomized to either feed SpoonfulONE daily, or non-intervention control allowing parent-led food allergen introduction. The study will follow infants for up to 18 months (until age 22-24 months).